Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and
other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven
by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused
by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or
other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held
by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product
candidates in the timelines currently anticipated; Gilead's ability to
receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over
other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product
candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or
other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and
other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Among the
other Democrats still in the running for the seat vacated on Jan. 1
by Westchester County Executive George Latimer are People for Bernie co-founder Kat Brezler, who
received the endorsement yesterday of 2014 Democratic gubernatorial
candidate Zephyr Teachout; and Bedford Supervisor Chris Burdick.
In the race for the 21st, four out of the five Democrats and Ms. Stefanik have
received donations flagged
by the political finance website OpenSecrets.org as coming from political action committees or
other candidate committees, as of the last filing date on March 31.
[83][84] In the 2009 gubernatorial election, Republican Chris Christie
received 2,037 votes (51.7 % vs. 45.8 % countywide), ahead of Democrat Jon Corzine with 1,663 votes (42.2 % vs. 48.0 %), Independent Chris Daggett with 181 votes (4.6 % vs. 4.7 %) and
other candidates with 24 votes (0.6 % vs. 0.5 %), among the 3,937 ballots cast
by the borough's 7,449 registered voters, yielding a 52.9 % turnout (vs. 50.0 % in the county).
[94][95] In the 2009 gubernatorial election, Democrat Jon Corzine
received 2,204 ballots cast (47.2 % vs. 48.0 % countywide), ahead of Republican Chris Christie with 2,116 votes (45.3 % vs. 45.8 %), Independent Chris Daggett with 299 votes (6.4 % vs. 4.7 %) and
other candidates with 11 votes (0.2 % vs. 0.5 %), among the 4,666 ballots cast
by the borough's 8,203 registered voters, yielding a 56.9 % turnout (vs. 50.0 % in the county).
But if a third, progressive
candidate entered the race, then the governor led
by just 15 points, with the two
others each
receiving one quarter of the vote, says Greenberg.
[155][156] In the 2009 gubernatorial election, Democrat Jon Corzine
received 62.3 % of the vote here (9,095 ballots cast), ahead of Republican Chris Christie with 29.5 % (4,307 votes), Independent Chris Daggett with 4.6 % (673 votes) and
other candidates with 0.9 % (138 votes), among the 14,593 ballots cast
by the city's 34,844 registered voters, yielding a 41.9 % turnout.
But if there were a third, progressive
candidate, then the governor would lead
by just 15 points, with the two
others each
receiving one - quarter of the vote, says Greenberg.
Assemblyman Danny O'Donnell and a dozen
other candidates over the next two days will be interviewed
by the Senate and Assembly, hoping to
receive a legislative appointment for the job of attorney general.
Any single contribution of $ 5,000 or more for a statewide office, $ 1,000 or more for the General Assembly, or $ 500 or more for any
other office, knowingly
received or reported
by the
candidate or his treasurer on behalf of his candidacy on and after the 12th day preceding a primary and before the primary date, on and after the 12th day preceding a general election and before the general election date, or on and after the 11th day preceding any
other election in which the individual is a
candidate and before the election day, must be reported in writing or electronically to the State Board of Elections.
Perhaps this view will become the new
received wisdom — it's quoted in today's NYTimes column
by economist Paul Krugman, «Grains Gone Wild,» who cites «the rise of demon ethanol and
other biofuels,» and points out, «Oh, and in case you're wondering: all the remaining presidential
candidates are terrible on this issue.»
48 (1) The elector on
receiving a ballot shall forthwith proceed to one of the voting screens and there, using a pencil or pen indicate the
candidate of his or her choice
by marking one of the circular spaces on the ballot with a cross or
other mark in any colour.
Receiving a response to a manual résumé submission is rare due to the volume of applications many employers
receive — so notification
by the ATS that the application has been rejected allows the
candidate to pursue
other opportunities to be considered for the role (i.e., using networking contacts), to tweak the résumé, or to simply move on.
Thus in order to ensure the fact that the
candidate's resume becomes a pleasant read for the concerned authorities contrary to the casual and hasty glance
received by the
other lot of resume irrespective of the impressive facts that they may have to convey, the facts in the figures should not only be remarkable and striking but also pertinent, relevant and discreet to some extent.
Other employers are so overwhelmed
by the mass number of resumes they
receive daily that they streamline their hiring process
by digitizing resumes, storing them in a database, searching for ideal
candidates using keywords, and then using the results to create an interview call list.
True, some hiring managers and recruiters have gone on the record and said they pitch cover letters, yet
others proclaim just the opposite, stating the cover letter is the most important document written and
received by a
candidate.